Oruka Therapeutics (ORKA) News Today $15.04 -0.23 (-1.51%) As of 01:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ORKA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Oruka Therapeutics, Inc. $ORKA Shares Bought by Affinity Asset Advisors LLCAugust 28 at 9:02 AM | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Stock Price Down 5.8% - What's Next?August 27 at 3:51 PM | marketbeat.comCandriam S.C.A. Purchases Shares of 116,698 Oruka Therapeutics, Inc. $ORKAAugust 26 at 4:50 AM | marketbeat.comQ3 EPS Forecast for Oruka Therapeutics Decreased by AnalystAugust 22, 2025 | marketbeat.comHC Wainwright Issues Negative Estimate for ORKA EarningsAugust 22, 2025 | americanbankingnews.comOruka Therapeutics initiated with a Buy at Clear StreetAugust 21, 2025 | msn.comOruka Therapeutics (NASDAQ:ORKA) Earns Buy Rating from HC WainwrightAugust 20, 2025 | marketbeat.comHC Wainwright Reiterates Buy Rating for Oruka Therapeutics (NASDAQ:ORKA)August 20, 2025 | americanbankingnews.comOruka Therapeutics (ORKA) Receives a Buy from H.C. WainwrightAugust 19, 2025 | theglobeandmail.comOruka Therapeutics (NASDAQ:ORKA) Rating Lowered to "Sell" at Wall Street ZenAugust 18, 2025 | americanbankingnews.comWedbush Forecasts Reduced Earnings for Oruka TherapeuticsAugust 17, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Downgraded by Wall Street Zen to "Sell"August 17, 2025 | marketbeat.comQ3 EPS Forecast for Oruka Therapeutics Reduced by AnalystAugust 16, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Is In A Good Position To Deliver On Growth PlansAugust 15, 2025 | finance.yahoo.comOruka Therapeutics (NASDAQ:ORKA) Trading 7.1% Higher - Here's WhyAugust 15, 2025 | marketbeat.comOruka Therapeutics' (ORKA) "Outperform" Rating Reiterated at WedbushAugust 13, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPSAugust 12, 2025 | marketbeat.comOruka Therapeutics reports Q2 EPS (46c), consensus (43c)August 12, 2025 | msn.comOruka Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate UpdateAugust 11, 2025 | globenewswire.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Average Recommendation of "Buy" from AnalystsAugust 10, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Trading Down 9.4% - Here's WhyAugust 7, 2025 | marketbeat.comTD Asset Management Inc Decreases Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA)August 5, 2025 | marketbeat.comJefferies Financial Group Inc. Grows Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA)August 3, 2025 | marketbeat.comOruka Therapeutics (ORKA) Expected to Announce Earnings on ThursdayJuly 31, 2025 | marketbeat.comOruka Therapeutics stock rises after FDA clears IND for psoriasis drugJuly 22, 2025 | investing.comOruka Therapeutics Shares Climb After FDA Greenlights Psoriasis Drug TrialJuly 22, 2025 | msn.comWedbush Reiterates Outperform Rating for Oruka Therapeutics (NASDAQ:ORKA)July 21, 2025 | marketbeat.comOruka Therapeutics Announces IND Clearance for EVERLAST-A Phase 2a Trial of ORKA-001 in Psoriasis with Phase 1 Data to be Presented at EADV in SeptemberJuly 21, 2025 | globenewswire.comOruka Therapeutics (NASDAQ:ORKA) Shares Down 6.8% - Time to Sell?July 19, 2025 | marketbeat.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Receives Consensus Rating of "Buy" from AnalystsJuly 15, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Shares Up 7.4% - What's Next?July 7, 2025 | marketbeat.comOruka Therapeutics Announces Promotion of Laura Sandler to Oper Chief >ORKAJuly 3, 2025 | marketwatch.comOruka Therapeutics Announces Promotion of Laura Sandler to Chief Operating OfficerJuly 1, 2025 | globenewswire.comOruka Therapeutics (NASDAQ:ORKA) Upgraded by Wall Street Zen to "Hold" RatingJune 22, 2025 | marketbeat.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Given Average Recommendation of "Buy" by AnalystsJune 20, 2025 | marketbeat.comWall Street Zen Downgrades Oruka Therapeutics (NASDAQ:ORKA) to SellJune 14, 2025 | marketbeat.comMillennium Management LLC Makes New Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA)June 8, 2025 | marketbeat.comToronto Dominion Bank Takes Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA)June 1, 2025 | marketbeat.comORKA Oruka Therapeutics, Inc.May 30, 2025 | seekingalpha.comQ2 EPS Estimate for Oruka Therapeutics Boosted by AnalystMay 30, 2025 | marketbeat.comNorthern Trust Corp Acquires Shares of 64,044 Oruka Therapeutics, Inc. (NASDAQ:ORKA)May 30, 2025 | marketbeat.comJefferies Financial Group Inc. Makes New $6.79 Million Investment in Oruka Therapeutics, Inc. (NASDAQ:ORKA)May 28, 2025 | marketbeat.comH.C. Wainwright Maintains Buy Rating on Oruka (ORKA) After the Early Start of OKRA-002 TrialMay 27, 2025 | insidermonkey.comOruka Therapeutics, Inc. (NASDAQ:ORKA) Given Consensus Recommendation of "Buy" by AnalystsMay 27, 2025 | marketbeat.com58,332 Shares in Oruka Therapeutics, Inc. (NASDAQ:ORKA) Purchased by Toronto Dominion BankMay 26, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Raised to Hold at StockNews.comMay 24, 2025 | marketbeat.comOruka Therapeutics (NASDAQ:ORKA) Coverage Initiated by Analysts at BTIG ResearchMay 24, 2025 | marketbeat.comFrazier Life Sciences Management L.P. Grows Holdings in Oruka Therapeutics, Inc. (NASDAQ:ORKA)May 23, 2025 | marketbeat.comVR Adviser LLC Buys 200,000 Shares of Oruka Therapeutics, Inc. (NASDAQ:ORKA)May 22, 2025 | marketbeat.comPoint72 Asset Management L.P. Cuts Position in Oruka Therapeutics, Inc. (NASDAQ:ORKA)May 22, 2025 | marketbeat.com Get Oruka Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ORKA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ORKA Media Mentions By Week ORKA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORKA News Sentiment▼0.921.03▲Average Medical News Sentiment ORKA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORKA Articles This Week▼43▲ORKA Articles Average Week Get the Latest News and Ratings for ORKA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oruka Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AGIO News Today IDYA News Today HRMY News Today OCUL News Today RXRX News Today IRON News Today BLTE News Today MESO News Today CGON News Today ANIP News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORKA) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oruka Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oruka Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access